Serial cytokine profiles in shunt-related ventriculitis treated with intraventricular vancomycin

Gary Laborada1, Florencia Cruz, Mirjana Nesin

  • 1Weill Medical College of Cornell University, New York, NY, USA.

Chemotherapy
|October 18, 2005
PubMed

Insights

Intraventricular vancomycin successfully treated methicillin-resistant Staphylococcus aureus ventriculitis in an infant when standard therapy failed. Cerebrospinal fluid sterilization correlated with reduced white blood cells and inflammatory cytokines.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurocritical Care
  • Antimicrobial Therapy

Background:

  • A premature infant presented with persistent shunt-related methicillin-resistant Staphylococcus aureus (MRSA) ventriculitis.
  • Parenteral vancomycin and gentamicin/rifampin therapy were ineffective against the infection.

Observation:

  • Treatment involved intraventricular vancomycin administration for 5 days.
  • Cerebrospinal fluid (CSF) analysis included standard testing and serial measurement of inflammatory cytokines (TNF-α, IL-8, IL-6).

Findings:

  • Intraventricular vancomycin led to CSF sterilization.
  • A decrease in white blood cell count and proinflammatory cytokines was observed post-treatment.

Implications:

  • Intraventricular antibiotic administration is a viable option for refractory ventriculitis.
  • Serial cytokine monitoring in CSF can aid in assessing therapeutic response.
Abstract